Since FAP- and Meso-CAR T cells exhibited similar functionality in vitro, we hypothesized that the greater anti-tumor activity of FAP-CAR T cells in vivo was at least partially due to their unique ability to overcome the physical barriers and immunosuppressive milieu imposed by FAP+ stromal cells in the TME. This evidence concerns the gene FAP and neoplasm.